Quanterix Corporation (QTRX) Q4 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call indicates a strong financial performance with a 12% revenue increase, improved gross margins, and reduced net loss. Positive cash flow from operations and strategic investments in R&D support growth prospects. Despite acknowledging risks in forward-looking statements, the overall sentiment is positive due to improved financial metrics and operational efficiency.
Key Financial Performance
Revenue Revenue for Q4 2025 was $35.2 million, representing a 12% increase year-over-year. This growth was driven by strong demand for our biomarker detection solutions and expanded customer base.
Gross Margin Gross margin improved to 58% in Q4 2025, up from 54% in Q4 2024. The improvement was attributed to operational efficiencies and cost management initiatives.
Net Loss Net loss for Q4 2025 was $4.8 million, compared to a net loss of $6.2 million in Q4 2024. The reduction in net loss was due to higher revenue and improved gross margins.
Operating Expenses Operating expenses were $22.5 million in Q4 2025, a 5% increase year-over-year. The increase was primarily due to investments in R&D and sales infrastructure.
Cash Flow Cash flow from operations was positive at $3.1 million in Q4 2025, compared to negative $1.5 million in Q4 2024. This improvement was driven by better working capital management and higher revenue.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Forward-looking statements: The company acknowledges that forward-looking statements involve known and unknown risks, uncertainties, assumptions, and other factors that may cause actual results, performance, or achievements to differ materially from expectations.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Forward-looking statements: During the course of today's presentation, we will make forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act. These forward-looking statements are based on management's beliefs and assumptions as of today, March 2, 2026. We may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties, assumptions and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by forward-looking statements.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Review of Unclear Management Responses
A:
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Alexander Vukasin
CEO Director
CFO Treasurer
Canaccord Genuity
Colby conference
Corp Research
Cunningham President
DeBourcy Nephron
Director Vandana
Division Puneet
Division Tom
EST Ladies
Everett Cunningham
Genuity Corp
LLC PM
LLC Research
Nephron Research
PM EST
Partners LLC
Quanterix Instructions
Relations Everett
Research Division
Research LLC
Sriram CFO
Tom DeBourcy
Treasurer Alexander
Vukasin Canaccord
gentleman name
name Colby
today Quanterix
QTRX Transcript
Quanterix Corporation (QTRX) Q4 2025 Earnings Call Transcript
Positive3-3
The earnings call indicates a strong financial performance with a 12% revenue increase, improved gross margins, and reduced net loss. Positive cash flow from operations and strategic investments in R&D support growth prospects. Despite acknowledging risks in forward-looking statements, the overall sentiment is positive due to improved financial metrics and operational efficiency.
Quanterix Corporation (QTRX) Q3 2025 Earnings Call Transcript
Unknown11-10
The earnings call summary shows mixed signals. The company has optimistic guidance and potential market expansion, but faces current financial challenges with losses and reduced cash position. The Q&A highlights concerns about government shutdown impact, market uncertainties, and lack of specific guidance. Despite these, there are positive notes on synergies, Medicare traction, and cross-selling opportunities. However, the lack of guidance and financial losses balance out the positives, leading to a neutral sentiment.
Quanterix Corporation (QTRX) Q2 2025 Earnings Call Transcript
Unknown8-9
The earnings call reveals significant challenges, including a substantial revenue decline, goodwill impairment, and increased operational expenses. Despite some positive developments like a rise in sales to diagnostics partners, the overall financial performance is concerning, with a notable loss in adjusted EBITDA. The Q&A section suggests some optimism but also highlights ongoing market uncertainties and dependence on external conditions. The strategic initiatives and cost reductions may offer future benefits, but current financial metrics and guidance indicate a negative outlook for the stock price in the short term.
Quanterix Corporation (NASDAQ:QTRX) Q1 2025 Earnings Call Transcript
Unknown5-13
The earnings call reveals mixed financial performance, with declining revenue and increasing losses, despite some positive aspects like consumables growth and cost reduction plans. The Q&A highlights concerns about declining large projects and economic pressures, while management's vague responses add uncertainty. The 2025 guidance shows modest growth expectations, but the lack of strong financial performance and cautious market environment suggest a negative stock reaction.
QTRX Slides
QTRX Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
